340 related articles for article (PubMed ID: 18408193)
1. Antimicrobial efficacy of riboflavin/UVA combination (365 nm) in vitro for bacterial and fungal isolates: a potential new treatment for infectious keratitis.
Martins SA; Combs JC; Noguera G; Camacho W; Wittmann P; Walther R; Cano M; Dick J; Behrens A
Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3402-8. PubMed ID: 18408193
[TBL] [Abstract][Full Text] [Related]
2. In vitro efficacy of antifungal treatment using riboflavin/UV-A (365 nm) combination and amphotericin B.
Sauer A; Letscher-Bru V; Speeg-Schatz C; Touboul D; Colin J; Candolfi E; Bourcier T
Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):3950-3. PubMed ID: 20335618
[TBL] [Abstract][Full Text] [Related]
3. In vitro antimicrobial efficacy of riboflavin and ultraviolet light on Staphylococcus aureus, methicillin-resistant Staphylococcus aureus, and Pseudomonas aeruginosa.
Schrier A; Greebel G; Attia H; Trokel S; Smith EF
J Refract Surg; 2009 Sep; 25(9):S799-802. PubMed ID: 19772254
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic UVA-riboflavin bacterial elimination in antibiotic-resistant bacteria.
Makdoumi K; Bäckman A
Clin Exp Ophthalmol; 2016 Sep; 44(7):582-586. PubMed ID: 26867998
[TBL] [Abstract][Full Text] [Related]
5. An experimental study on antimicrobial activity of silicone oil in vitro.
Yan H; Li J
Ophthalmologica; 2008; 222(4):245-8. PubMed ID: 18467849
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of antibacterial efficacy of photo-activated riboflavin using ultraviolet light (UVA).
Makdoumi K; Bäckman A; Mortensen J; Crafoord S
Graefes Arch Clin Exp Ophthalmol; 2010 Feb; 248(2):207-12. PubMed ID: 19921518
[TBL] [Abstract][Full Text] [Related]
7. In vitro susceptibility of canine corneal bacterial pathogens to three cross-linking protocols.
Large TP; Mack S; Villiers E; Oliver J
Vet Ophthalmol; 2023 Apr; 26 Suppl 1():134-142. PubMed ID: 35713165
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial susceptibility of photodynamic therapy (UVA/riboflavin) against Staphylococcus aureus.
Kashiwabuchi RT; Khan Y; Carvalho FR; Hirai F; Campos MS; McDonnell PJ
Arq Bras Oftalmol; 2012; 75(6):423-6. PubMed ID: 23715147
[TBL] [Abstract][Full Text] [Related]
9. The effect of UV-light on human skin microorganisms.
Faergemann J; Larkö O
Acta Derm Venereol; 1987; 67(1):69-72. PubMed ID: 2436418
[TBL] [Abstract][Full Text] [Related]
10. Effect of saliva on an antimicrobial tissue conditioner containing silver-zeolite.
Abe Y; Ishii M; Takeuchi M; Ueshige M; Tanaka S; Akagawa Y
J Oral Rehabil; 2004 Jun; 31(6):568-73. PubMed ID: 15189314
[TBL] [Abstract][Full Text] [Related]
11. Bactericidal effect of photo-activated riboflavin using UVA.
Wiwanitkit V
Graefes Arch Clin Exp Ophthalmol; 2010 May; 248(5):755; author reply 757-8. PubMed ID: 20091179
[No Abstract] [Full Text] [Related]
12. The efficiency of cross-linking methods in eradication of bacteria is influenced by the riboflavin concentration and the irradiation time of ultraviolet light.
Bäckman A; Makdoumi K; Mortensen J; Crafoord S
Acta Ophthalmol; 2014 Nov; 92(7):656-61. PubMed ID: 25493311
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of antimicrobial properties of silicon oil--in vitro studies].
Mackiewicz J; Kozioł-Montewka M; Kosior-Jarecka E; Szczepanik A; Wójtowicz M; Zagórski Z
Klin Oczna; 2004; 106(3 Suppl):434-5. PubMed ID: 15636227
[TBL] [Abstract][Full Text] [Related]
14. The antimicrobial spectrum of Xeroform
Barillo DJ; Barillo AR; Korn S; Lam K; Attar PS
Burns; 2017 Sep; 43(6):1189-1194. PubMed ID: 28641915
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety assessment of a novel ultraviolet C device for treating corneal bacterial infections.
Dean SJ; Petty A; Swift S; McGhee JJ; Sharma A; Shah S; Craig JP
Clin Exp Ophthalmol; 2011 Mar; 39(2):156-63. PubMed ID: 21105972
[TBL] [Abstract][Full Text] [Related]
16. Risk factors and causative organisms in microbial keratitis.
Green M; Apel A; Stapleton F
Cornea; 2008 Jan; 27(1):22-7. PubMed ID: 18245962
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial Studies Using the Therapeutic Tissue Cross-Linking Agent, Sodium Hydroxymethylglycinate: Implication for Treating Infectious Keratitis.
Rapuano PB; Scanameo AH; Amponin DE; Paulose SA; Zyablitskaya M; Takaoka A; Suh LH; Nagasaki T; Trokel SL; Paik DC
Invest Ophthalmol Vis Sci; 2018 Jan; 59(1):332-337. PubMed ID: 29346493
[TBL] [Abstract][Full Text] [Related]
18. Antibacterial efficacy of accelerated photoactivated chromophore for keratitis-corneal collagen cross-linking (PACK-CXL).
Richoz O; Kling S; Hoogewoud F; Hammer A; Tabibian D; Francois P; Schrenzel J; Hafezi F
J Refract Surg; 2014 Dec; 30(12):850-4. PubMed ID: 25437485
[TBL] [Abstract][Full Text] [Related]
19.
Sharma A; Sharma R; Chander J; Nirankari VS
Taiwan J Ophthalmol; 2023; 13(1):21-27. PubMed ID: 37252159
[TBL] [Abstract][Full Text] [Related]
20. Riboflavin/UVA photochemical therapy for severe infectious keratitis.
Skaat A; Zadok D; Goldich Y; Varssano D; Berger Y; Ezra-Nimni O; Avni I; Barequet IS
Eur J Ophthalmol; 2014; 24(1):21-8. PubMed ID: 23873492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
